Clinical Trial Update: Novartis Everolimus Transition [Phase 4]

View source ↗

Summary

Clinical trial update for Everolimus transition in phase 4 completed; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft Dysfunction
• Interstitial Fibrosis

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Graft Dysfunction, Interstitial Fibrosis | Phase 4 | Status: COMPLETED | Results posted: 2018-08-08